Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting
Conjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these biomaterials often depends on the overexpression of the targeted receptor, we set out to survey expression of transferrin receptor (TfR) in primary and me...
Saved in:
| Published in | PloS one Vol. 18; no. 12; p. e0293700 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
20.12.2023
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0293700 |
Cover
| Abstract | Conjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these biomaterials often depends on the overexpression of the targeted receptor, we set out to survey expression of transferrin receptor (TfR) in primary and metastatic breast cancer samples, including metastases and relapse, and investigate its modulation in experimental models.
Gene expression was investigated by datamining in twelve publicly-available datasets. Dedicated Tissue microarrays (TMAs) were generated to evaluate matched primary and bone metastases as well as and pre and post chemotherapy tumors from the same patient. TMA were stained with the FDA-approved MRQ-48 antibody against TfR and graded by staining intensity (H-score). Patient-derived xenografts (PDX) and isogenic metastatic mouse models were used to study in vivo TfR expression and uptake of transferrin.
TFRC gene and protein expression were high in breast cancer of all subtypes and stages, and in 60-85% of bone metastases. TfR was detectable after neoadjuvant chemotherapy, albeit with some variability. Fluorophore-conjugated transferrin iron chelator deferoxamine (DFO) enhanced TfR uptake in human breast cancer cells in vitro and proved transferrin localization at metastatic sites and correlation of tumor burden relative to untreated tumor mice.
TfR is expressed in breast cancer, primary, metastatic, and after neoadjuvant chemotherapy. Variability in expression of TfR suggests that evaluation of the expression of TfR in individual patients could identify the best candidates for targeting. Further, systemic iron chelation with DFO may upregulate receptor expression and improve uptake of therapeutics or tracers that use transferrin as a homing ligand. |
|---|---|
| AbstractList | Background Conjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these biomaterials often depends on the overexpression of the targeted receptor, we set out to survey expression of transferrin receptor (TfR) in primary and metastatic breast cancer samples, including metastases and relapse, and investigate its modulation in experimental models. Methods Gene expression was investigated by datamining in twelve publicly-available datasets. Dedicated Tissue microarrays (TMAs) were generated to evaluate matched primary and bone metastases as well as and pre and post chemotherapy tumors from the same patient. TMA were stained with the FDA-approved MRQ-48 antibody against TfR and graded by staining intensity (H-score). Patient-derived xenografts (PDX) and isogenic metastatic mouse models were used to study in vivo TfR expression and uptake of transferrin. Results TFRC gene and protein expression were high in breast cancer of all subtypes and stages, and in 60-85% of bone metastases. TfR was detectable after neoadjuvant chemotherapy, albeit with some variability. Fluorophore-conjugated transferrin iron chelator deferoxamine (DFO) enhanced TfR uptake in human breast cancer cells in vitro and proved transferrin localization at metastatic sites and correlation of tumor burden relative to untreated tumor mice. Conclusions TfR is expressed in breast cancer, primary, metastatic, and after neoadjuvant chemotherapy. Variability in expression of TfR suggests that evaluation of the expression of TfR in individual patients could identify the best candidates for targeting. Further, systemic iron chelation with DFO may upregulate receptor expression and improve uptake of therapeutics or tracers that use transferrin as a homing ligand. Conjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these biomaterials often depends on the overexpression of the targeted receptor, we set out to survey expression of transferrin receptor (TfR) in primary and metastatic breast cancer samples, including metastases and relapse, and investigate its modulation in experimental models. Gene expression was investigated by datamining in twelve publicly-available datasets. Dedicated Tissue microarrays (TMAs) were generated to evaluate matched primary and bone metastases as well as and pre and post chemotherapy tumors from the same patient. TMA were stained with the FDA-approved MRQ-48 antibody against TfR and graded by staining intensity (H-score). Patient-derived xenografts (PDX) and isogenic metastatic mouse models were used to study in vivo TfR expression and uptake of transferrin. TFRC gene and protein expression were high in breast cancer of all subtypes and stages, and in 60-85% of bone metastases. TfR was detectable after neoadjuvant chemotherapy, albeit with some variability. Fluorophore-conjugated transferrin iron chelator deferoxamine (DFO) enhanced TfR uptake in human breast cancer cells in vitro and proved transferrin localization at metastatic sites and correlation of tumor burden relative to untreated tumor mice. TfR is expressed in breast cancer, primary, metastatic, and after neoadjuvant chemotherapy. Variability in expression of TfR suggests that evaluation of the expression of TfR in individual patients could identify the best candidates for targeting. Further, systemic iron chelation with DFO may upregulate receptor expression and improve uptake of therapeutics or tracers that use transferrin as a homing ligand. Conjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these biomaterials often depends on the overexpression of the targeted receptor, we set out to survey expression of transferrin receptor (TfR) in primary and metastatic breast cancer samples, including metastases and relapse, and investigate its modulation in experimental models.BACKGROUNDConjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these biomaterials often depends on the overexpression of the targeted receptor, we set out to survey expression of transferrin receptor (TfR) in primary and metastatic breast cancer samples, including metastases and relapse, and investigate its modulation in experimental models.Gene expression was investigated by datamining in twelve publicly-available datasets. Dedicated Tissue microarrays (TMAs) were generated to evaluate matched primary and bone metastases as well as and pre and post chemotherapy tumors from the same patient. TMA were stained with the FDA-approved MRQ-48 antibody against TfR and graded by staining intensity (H-score). Patient-derived xenografts (PDX) and isogenic metastatic mouse models were used to study in vivo TfR expression and uptake of transferrin.METHODSGene expression was investigated by datamining in twelve publicly-available datasets. Dedicated Tissue microarrays (TMAs) were generated to evaluate matched primary and bone metastases as well as and pre and post chemotherapy tumors from the same patient. TMA were stained with the FDA-approved MRQ-48 antibody against TfR and graded by staining intensity (H-score). Patient-derived xenografts (PDX) and isogenic metastatic mouse models were used to study in vivo TfR expression and uptake of transferrin.TFRC gene and protein expression were high in breast cancer of all subtypes and stages, and in 60-85% of bone metastases. TfR was detectable after neoadjuvant chemotherapy, albeit with some variability. Fluorophore-conjugated transferrin iron chelator deferoxamine (DFO) enhanced TfR uptake in human breast cancer cells in vitro and proved transferrin localization at metastatic sites and correlation of tumor burden relative to untreated tumor mice.RESULTSTFRC gene and protein expression were high in breast cancer of all subtypes and stages, and in 60-85% of bone metastases. TfR was detectable after neoadjuvant chemotherapy, albeit with some variability. Fluorophore-conjugated transferrin iron chelator deferoxamine (DFO) enhanced TfR uptake in human breast cancer cells in vitro and proved transferrin localization at metastatic sites and correlation of tumor burden relative to untreated tumor mice.TfR is expressed in breast cancer, primary, metastatic, and after neoadjuvant chemotherapy. Variability in expression of TfR suggests that evaluation of the expression of TfR in individual patients could identify the best candidates for targeting. Further, systemic iron chelation with DFO may upregulate receptor expression and improve uptake of therapeutics or tracers that use transferrin as a homing ligand.CONCLUSIONSTfR is expressed in breast cancer, primary, metastatic, and after neoadjuvant chemotherapy. Variability in expression of TfR suggests that evaluation of the expression of TfR in individual patients could identify the best candidates for targeting. Further, systemic iron chelation with DFO may upregulate receptor expression and improve uptake of therapeutics or tracers that use transferrin as a homing ligand. BackgroundConjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these biomaterials often depends on the overexpression of the targeted receptor, we set out to survey expression of transferrin receptor (TfR) in primary and metastatic breast cancer samples, including metastases and relapse, and investigate its modulation in experimental models.MethodsGene expression was investigated by datamining in twelve publicly-available datasets. Dedicated Tissue microarrays (TMAs) were generated to evaluate matched primary and bone metastases as well as and pre and post chemotherapy tumors from the same patient. TMA were stained with the FDA-approved MRQ-48 antibody against TfR and graded by staining intensity (H-score). Patient-derived xenografts (PDX) and isogenic metastatic mouse models were used to study in vivo TfR expression and uptake of transferrin.ResultsTFRC gene and protein expression were high in breast cancer of all subtypes and stages, and in 60-85% of bone metastases. TfR was detectable after neoadjuvant chemotherapy, albeit with some variability. Fluorophore-conjugated transferrin iron chelator deferoxamine (DFO) enhanced TfR uptake in human breast cancer cells in vitro and proved transferrin localization at metastatic sites and correlation of tumor burden relative to untreated tumor mice.ConclusionsTfR is expressed in breast cancer, primary, metastatic, and after neoadjuvant chemotherapy. Variability in expression of TfR suggests that evaluation of the expression of TfR in individual patients could identify the best candidates for targeting. Further, systemic iron chelation with DFO may upregulate receptor expression and improve uptake of therapeutics or tracers that use transferrin as a homing ligand. Conjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these biomaterials often depends on the overexpression of the targeted receptor, we set out to survey expression of transferrin receptor (TfR) in primary and metastatic breast cancer samples, including metastases and relapse, and investigate its modulation in experimental models. Gene expression was investigated by datamining in twelve publicly-available datasets. Dedicated Tissue microarrays (TMAs) were generated to evaluate matched primary and bone metastases as well as and pre and post chemotherapy tumors from the same patient. TMA were stained with the FDA-approved MRQ-48 antibody against TfR and graded by staining intensity (H-score). Patient-derived xenografts (PDX) and isogenic metastatic mouse models were used to study in vivo TfR expression and uptake of transferrin. TFRC gene and protein expression were high in breast cancer of all subtypes and stages, and in 60-85% of bone metastases. TfR was detectable after neoadjuvant chemotherapy, albeit with some variability. Fluorophore-conjugated transferrin iron chelator deferoxamine (DFO) enhanced TfR uptake in human breast cancer cells in vitro and proved transferrin localization at metastatic sites and correlation of tumor burden relative to untreated tumor mice. TfR is expressed in breast cancer, primary, metastatic, and after neoadjuvant chemotherapy. Variability in expression of TfR suggests that evaluation of the expression of TfR in individual patients could identify the best candidates for targeting. Further, systemic iron chelation with DFO may upregulate receptor expression and improve uptake of therapeutics or tracers that use transferrin as a homing ligand. Background Conjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these biomaterials often depends on the overexpression of the targeted receptor, we set out to survey expression of transferrin receptor (TfR) in primary and metastatic breast cancer samples, including metastases and relapse, and investigate its modulation in experimental models. Methods Gene expression was investigated by datamining in twelve publicly-available datasets. Dedicated Tissue microarrays (TMAs) were generated to evaluate matched primary and bone metastases as well as and pre and post chemotherapy tumors from the same patient. TMA were stained with the FDA-approved MRQ-48 antibody against TfR and graded by staining intensity (H-score). Patient-derived xenografts (PDX) and isogenic metastatic mouse models were used to study in vivo TfR expression and uptake of transferrin. Results TFRC gene and protein expression were high in breast cancer of all subtypes and stages, and in 60–85% of bone metastases. TfR was detectable after neoadjuvant chemotherapy, albeit with some variability. Fluorophore-conjugated transferrin iron chelator deferoxamine (DFO) enhanced TfR uptake in human breast cancer cells in vitro and proved transferrin localization at metastatic sites and correlation of tumor burden relative to untreated tumor mice. Conclusions TfR is expressed in breast cancer, primary, metastatic, and after neoadjuvant chemotherapy. Variability in expression of TfR suggests that evaluation of the expression of TfR in individual patients could identify the best candidates for targeting. Further, systemic iron chelation with DFO may upregulate receptor expression and improve uptake of therapeutics or tracers that use transferrin as a homing ligand. |
| Audience | Academic |
| Author | Li, Shunqiang Achilefu, Samuel Kwakwa, Kristin A. Lanza, Gregory M. Karmakar, Partha Xu, Yalin Fontana, Francesca Park, Haeseong Manion, Brad Weilbaecher, Katherine N. Egbulefu, Christopher Su, Xinming Esser, Alison K. Allen, John S. Xiang, Jingyu Bakewell, Suzanne Davis, Jennifer L. Gabay, Ariel |
| AuthorAffiliation | Lady Davis Institute for Medical Research, CANADA 3 Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States of America 2 Department of Radiology, Washington University School of Medicine, St. Louis, MO, United States of America 1 Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States of America |
| AuthorAffiliation_xml | – name: 1 Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States of America – name: Lady Davis Institute for Medical Research, CANADA – name: 3 Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States of America – name: 2 Department of Radiology, Washington University School of Medicine, St. Louis, MO, United States of America |
| Author_xml | – sequence: 1 givenname: Francesca orcidid: 0000-0002-5889-9413 surname: Fontana fullname: Fontana, Francesca – sequence: 2 givenname: Alison K. surname: Esser fullname: Esser, Alison K. – sequence: 3 givenname: Christopher surname: Egbulefu fullname: Egbulefu, Christopher – sequence: 4 givenname: Partha surname: Karmakar fullname: Karmakar, Partha – sequence: 5 givenname: Xinming surname: Su fullname: Su, Xinming – sequence: 6 givenname: John S. surname: Allen fullname: Allen, John S. – sequence: 7 givenname: Yalin surname: Xu fullname: Xu, Yalin – sequence: 8 givenname: Jennifer L. surname: Davis fullname: Davis, Jennifer L. – sequence: 9 givenname: Ariel surname: Gabay fullname: Gabay, Ariel – sequence: 10 givenname: Jingyu surname: Xiang fullname: Xiang, Jingyu – sequence: 11 givenname: Kristin A. surname: Kwakwa fullname: Kwakwa, Kristin A. – sequence: 12 givenname: Brad surname: Manion fullname: Manion, Brad – sequence: 13 givenname: Suzanne surname: Bakewell fullname: Bakewell, Suzanne – sequence: 14 givenname: Shunqiang surname: Li fullname: Li, Shunqiang – sequence: 15 givenname: Haeseong surname: Park fullname: Park, Haeseong – sequence: 16 givenname: Gregory M. surname: Lanza fullname: Lanza, Gregory M. – sequence: 17 givenname: Samuel surname: Achilefu fullname: Achilefu, Samuel – sequence: 18 givenname: Katherine N. orcidid: 0000-0002-7137-4742 surname: Weilbaecher fullname: Weilbaecher, Katherine N. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38117806$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk99qFDEUxgdR7B99A9EBQfRi12Qyk8z0RkqpWigUtHobzmZOtimZZE0ypT6Gb2y2Oy3dUkTmIicnv--EfHPOXvHUeYdF8YqSOWWCfrz0Y3Bg56ucnpOqY4KQJ8Uu7Vg14xVhT-_FO8VejJeENKzl_Hmxw1pKRUv4bvHnPICLGkMwrgyocJV8KHO8CmaA8LsE15cDJogJklHlImAOSwVOYTgoj6_AjvnAu9LrEq9XAWNc79ayvMVcBV0CWw6-H-2GTL40wyr4K8xZiyrnQ5kgLDEZt3xRPNNgI76c1v3ix-fj86Ovs9OzLydHh6czxTuWZqIjHDR2CkVbcU5BQM-A6QVpdQNaLSpk7YKBbjmjUClOFak5WdSdIDWoju0XbzZ1V9ZHObkZJSMie0nrps7EyYboPVzKyRDpwcibhA9LCSGbYlF2hCAhbd80qq47pTvsey1aIfquplBDrvVpum1cDNirbEoAu1V0-8SZC7n0V5ISwao6_8P94v1UIfhfI8YkBxMVWgsO_Rhl1ZG6EYzyKqNvH6CPP2-ilpBfYJz2-WK1LioPheAtJQ3hmZo_QuWvx8Go3Hva5PyW4MOWIDMJr9MSxhjlyfdv_8-e_dxm391jLxBsuojejuuWitvg6_tW33l82_QZqDeACj7GgPoOoUSuZ-vWLrmeLTnNVpYdPJApk246Ojti7L_FfwH61i2D |
| CitedBy_id | crossref_primary_10_3390_ijms26062706 crossref_primary_10_3390_ijms25158252 crossref_primary_10_3390_pharmaceutics16091192 crossref_primary_10_3390_cancers16142544 |
| Cites_doi | 10.1371/journal.pone.0182689 10.1016/S0140-6736(80)90440-7 10.1371/journal.pone.0031875 10.1371/journal.pone.0251163 10.1038/s41467-023-37871-5 10.1007/BF01816434 10.1021/acs.molpharmaceut.8b01154 10.1016/S0140-6736(20)32381-3 10.1093/nar/30.1.207 10.4161/cc.6.14.4448 10.3324/haematol.2009.014696 10.1186/bcr1732 10.2967/jnumed.117.192286 10.1186/s13046-018-0737-z 10.1073/pnas.1811717115 10.1007/s10549-009-0651-3 10.1158/0008-5472.CAN-15-2663 10.1023/A:1006209714287 10.1007/s10549-020-05597-3 10.1186/s12920-019-0514-7 10.3322/caac.21590 10.1039/D0RA01878C 10.1038/ncomms15081 10.1016/j.jtemb.2019.01.004 10.1158/1535-7163.MCT-15-0252 10.1615/CritRevOncog.2013007784 10.1161/01.CIR.99.9.1222 10.1016/S0167-4889(98)00002-0 10.1152/ajpendo.00033.2011 10.3748/wjg.v22.i40.8967 10.1182/blood.V98.3.525 10.3758/BF03193146 10.7150/thno.45825 10.1002/jcb.21709 10.1371/journal.pone.0154842 10.1002/cpmb.49 10.1016/j.semcancer.2019.08.012 10.3892/or.2012.2060 10.1038/s41598-021-84146-4 10.1007/BF00710908 10.1159/000226727 10.1016/S0140-6736(17)33326-3 10.1186/s12885-018-4757-z 10.1007/BF01806791 10.1038/s41598-017-01402-2 10.1016/0140-6736(91)92978-B 10.2147/OTT.S193507 10.1007/s10549-009-0345-x 10.1186/s13058-015-0558-3 10.1038/srep38343 10.1056/NEJMc1105726 10.1369/jhc.2009.953554 10.1158/0008-5472.CAN-17-1225 10.1038/nature01266 10.1016/j.isci.2022.105799 10.1056/NEJMoa2209254 10.1016/j.canlet.2014.01.029 10.1186/s12885-020-07673-9 10.1038/nature08989 10.1371/journal.pcbi.1005352 10.1158/0008-5472.CAN-13-1224 10.1158/1078-0432.CCR-14-2155 10.1038/nnano.2015.17 10.1007/s10637-018-0703-9 10.1158/1078-0432.CCR-12-1000 10.1097/SAP.0000000000001655 10.1038/s41587-020-0546-8 10.1021/acsabm.8b00755 10.1158/0008-5472.CAN-05-3857 10.1016/j.chembiol.2018.10.009 10.1038/s41416-018-0318-0 10.3389/fimmu.2020.626812 10.1177/1533033818764470 10.1016/j.jconrel.2021.07.048 10.1371/journal.pone.0080269 10.1016/j.freeradbiomed.2005.03.029 10.1186/s13058-021-01468-x 10.1186/bcr3625 10.1371/journal.pone.0053983 10.1021/mp800149s 10.1073/pnas.2200200119 10.3892/mmr.2016.6004 10.1158/0008-5472.CAN-04-1844 10.1007/s00216-017-0664-4 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2023 Fontana et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. COPYRIGHT 2023 Public Library of Science 2023 Fontana et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 Fontana et al 2023 Fontana et al 2023 Fontana et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: Copyright: © 2023 Fontana et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: COPYRIGHT 2023 Public Library of Science – notice: 2023 Fontana et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 Fontana et al 2023 Fontana et al – notice: 2023 Fontana et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU COVID D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0293700 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Science (Gale In Context) ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection (ProQuest) ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College Coronavirus Research Database ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection Coronavirus Research Database ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Agricultural Science Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | Transferrin, molecular imaging, targeting, TfR, metastases, deferoxamine, iron, breast cancer |
| EISSN | 1932-6203 |
| ExternalDocumentID | 3072931454 oai_doaj_org_article_900e008d55c449cf9eddf7877d941a4a PMC10732420 A776810506 38117806 10_1371_journal_pone_0293700 |
| Genre | Journal Article |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GrantInformation_xml | – fundername: ; grantid: BCRP W81XWH16 1-0286 – fundername: ; grantid: RR027552 – fundername: ; grantid: CDI-CORE-2015-505, CDI-CORE-2019-813 – fundername: ; grantid: 3770 and 4642 – fundername: ; grantid: N/A – fundername: ; grantid: P01 CA100730 – fundername: ; grantid: R01 CA216840 – fundername: ; grantid: 5T32CA113275-07 and 5F32CA189671-02 – fundername: ; grantid: TR002345 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM ADRAZ BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K COVID DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 ESTFP PUEGO 5PM |
| ID | FETCH-LOGICAL-c693t-7906afe9ce782661a7ad3a3fb08f5afcb2e38b3af8631a2c61c0460b49704ac93 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Thu Nov 28 02:59:41 EST 2024 Wed Aug 27 01:31:19 EDT 2025 Thu Aug 21 18:37:38 EDT 2025 Sun Sep 28 09:32:25 EDT 2025 Fri Jul 25 10:16:55 EDT 2025 Tue Jun 17 22:21:29 EDT 2025 Tue Jun 10 21:15:53 EDT 2025 Fri Jun 27 06:06:00 EDT 2025 Fri Jun 27 05:51:43 EDT 2025 Thu May 22 21:17:10 EDT 2025 Thu Apr 03 07:06:11 EDT 2025 Tue Jul 01 01:02:51 EDT 2025 Thu Apr 24 22:55:57 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Language | English |
| License | Copyright: © 2023 Fontana et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c693t-7906afe9ce782661a7ad3a3fb08f5afcb2e38b3af8631a2c61c0460b49704ac93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: no authors have competing interests |
| ORCID | 0000-0002-7137-4742 0000-0002-5889-9413 |
| OpenAccessLink | https://www.proquest.com/docview/3072931454?pq-origsite=%requestingapplication%&accountid=15518 |
| PMID | 38117806 |
| PQID | 3072931454 |
| PQPubID | 1436336 |
| ParticipantIDs | plos_journals_3072931454 doaj_primary_oai_doaj_org_article_900e008d55c449cf9eddf7877d941a4a pubmedcentral_primary_oai_pubmedcentral_nih_gov_10732420 proquest_miscellaneous_2904573162 proquest_journals_3072931454 gale_infotracmisc_A776810506 gale_infotracacademiconefile_A776810506 gale_incontextgauss_ISR_A776810506 gale_incontextgauss_IOV_A776810506 gale_healthsolutions_A776810506 pubmed_primary_38117806 crossref_primary_10_1371_journal_pone_0293700 crossref_citationtrail_10_1371_journal_pone_0293700 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-12-20 |
| PublicationDateYYYYMMDD | 2023-12-20 |
| PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-20 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2023 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | MH Ross (pone.0293700.ref053) 2017; 77 PG Cavanaugh (pone.0293700.ref066) 1999; 56 W Wang (pone.0293700.ref015) 2014; 74 E Henriet (pone.0293700.ref061) 2023 C Nunez-Torron (pone.0293700.ref054) 2021 AL Vavere (pone.0293700.ref010) 2005; 46 T Triulzi (pone.0293700.ref039) 2018; 119 S Tabaries (pone.0293700.ref044) 2015; 17 DT Jones (pone.0293700.ref083) 2006; 66 SE Tonik (pone.0293700.ref063) 1986; 7 M Fryknas (pone.0293700.ref090) 2016; 6 D Saxena (pone.0293700.ref099) 2016; 11 WP Faulk (pone.0293700.ref020) 1980; 2 BT Martin (pone.0293700.ref067) 2007; 6 A Kuban-Jankowska (pone.0293700.ref030) 2017; 37 D Devos (pone.0293700.ref096) 2022; 387 J Xiang (pone.0293700.ref056) 2015; 14 ZC Soe (pone.0293700.ref009) 2019; 11 W Liang (pone.0293700.ref093) 2018; 115 M De Bortoli (pone.0293700.ref077) 2018; 37 Y Liang (pone.0293700.ref004) 2020; 60 L Ding (pone.0293700.ref057) 2010; 464 TB Chaston (pone.0293700.ref082) 2003; 9 C Ferreira (pone.0293700.ref080) 2001; 98 C Allemani (pone.0293700.ref003) 2018; 391 K Mody (pone.0293700.ref100) 2019; 37 J Chifman (pone.0293700.ref017) 2017; 13 M Miyazawa (pone.0293700.ref018) 2019; 26 JC Tseng (pone.0293700.ref026) 2017; 12 JC Allegra (pone.0293700.ref019) 1978; 38 F Braso-Maristany (pone.0293700.ref047) 2021 S Loibl (pone.0293700.ref089) 2021; 397 PG Betta (pone.0293700.ref065) 1989; 10 DR Crapper McLachlan (pone.0293700.ref102) 1991; 337 M Van Mechelen (pone.0293700.ref002) 2020; 181 SV Torti (pone.0293700.ref006) 2013; 18 BW Xie (pone.0293700.ref027) 2012; 7 DC Yang (pone.0293700.ref007) 2001; 21 CJ Creighton (pone.0293700.ref035) 2018; 121 KR Dassoulas (pone.0293700.ref032) 2019; 82 V Petrosyan (pone.0293700.ref072) 2023; 26 N Lim (pone.0293700.ref037) 2021 P Wigner (pone.0293700.ref012) 2021; 11 E Stickeler (pone.0293700.ref040) 2011; 26 O Marques (pone.0293700.ref016) 2014; 347 YH Choi (pone.0293700.ref068) 2012; 28 AK Dunbier (pone.0293700.ref038) 2013; 19 AA Ionkina (pone.0293700.ref046) 2021; 23 JJ Zoeller (pone.0293700.ref045) 2021; 16 F Wrba (pone.0293700.ref064) 1989; 46 L Vera-Ramirez (pone.0293700.ref071) 2013; 8 FM Yakes (pone.0293700.ref070) 2002; 62 NA Reed (pone.0293700.ref087) 2019; 2 KR Choudhury (pone.0293700.ref055) 2010; 58 A Mackay (pone.0293700.ref069) 2007; 9 O Uluckan (pone.0293700.ref074) 2008; 104 A Martin-Bastida (pone.0293700.ref095) 2017; 7 EM Hoke (pone.0293700.ref091) 2005; 39 KJ Weigel (pone.0293700.ref097) 2014; 6 M Li (pone.0293700.ref084) 2020; 20 MC Smith (pone.0293700.ref059) 2004; 64 Y Tan (pone.0293700.ref005) 2018; 410 DD Lane (pone.0293700.ref014) 2020; 10 XY He (pone.0293700.ref081) 2023; 14 J Yang (pone.0293700.ref028) 2017; 15 SJ Park (pone.0293700.ref034) 2019; 12 S Tajima (pone.0293700.ref078) 2012; 302 HO Habashy (pone.0293700.ref062) 2010; 119 R Edgar (pone.0293700.ref049) 2002; 30 I Saeki (pone.0293700.ref103) 2016; 22 W Goto (pone.0293700.ref031) 2020; 20 F Faul (pone.0293700.ref060) 2007; 39 W Liang (pone.0293700.ref092) 2020; 11 W Chung (pone.0293700.ref050) 2017; 8 RL Siegel (pone.0293700.ref001) 2020; 70 G Wang (pone.0293700.ref024) 2022; 119 BA Pulaski (pone.0293700.ref073) 2001 C Salvarani (pone.0293700.ref098) 1996; 16 MJ Goldman (pone.0293700.ref036) 2020; 38 RP McMullin (pone.0293700.ref048) 2014; 16 F Wrba (pone.0293700.ref021) 1986; 410 K Bajbouj (pone.0293700.ref033) 2018; 17 MD Cappellini (pone.0293700.ref094) 2010; 95 K Abe (pone.0293700.ref025) 2013; 8 T Yamasaki (pone.0293700.ref101) 2011; 365 H Yu (pone.0293700.ref088) 2019; 42 LA Korde (pone.0293700.ref041) 2010; 119 X Yang (pone.0293700.ref022) 2009; 6 Y Wei (pone.0293700.ref013) 2021; 337 A Rudkouskaya (pone.0293700.ref075) 2020; 10 C Chen (pone.0293700.ref076) 2019; 12 TS Lee (pone.0293700.ref079) 1999; 99 A Moore (pone.0293700.ref085) 1998; 1402 N Kotagiri (pone.0293700.ref023) 2015; 10 MA Naves (pone.0293700.ref086) 2019; 16 Y Okazaki (pone.0293700.ref052) 2002; 420 J McBryan (pone.0293700.ref043) 2015; 21 I Papatheodorou (pone.0293700.ref051) 2020; 48 X Su (pone.0293700.ref058) 2016; 76 B Li (pone.0293700.ref029) 2019; 52 S Hultsch (pone.0293700.ref042) 2018; 18 KE Henry (pone.0293700.ref008) 2018; 59 RL Elliott (pone.0293700.ref011) 1988; 12 |
| References_xml | – volume: 20 start-page: 57 year: 2020 ident: pone.0293700.ref084 article-title: Erastin triggers autophagic death of breast cancer cells by increasing intracellular iron levels publication-title: Oncol Lett – year: 2021 ident: pone.0293700.ref047 article-title: Gene expression profiles of breast cancer metastasis according to organ site publication-title: Mol Oncol – volume: 12 start-page: e0182689 year: 2017 ident: pone.0293700.ref026 article-title: Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism publication-title: PLoS One doi: 10.1371/journal.pone.0182689 – volume: 2 start-page: 390 year: 1980 ident: pone.0293700.ref020 article-title: Transferrin and transferrin receptors in carcinoma of the breast publication-title: Lancet doi: 10.1016/S0140-6736(80)90440-7 – volume: 7 start-page: e31875 year: 2012 ident: pone.0293700.ref027 article-title: Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model publication-title: PLoS One doi: 10.1371/journal.pone.0031875 – volume: 16 start-page: e0251163 year: 2021 ident: pone.0293700.ref045 article-title: Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy publication-title: PLoS One doi: 10.1371/journal.pone.0251163 – volume: 14 start-page: 2253 year: 2023 ident: pone.0293700.ref081 article-title: LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism publication-title: Nat Commun doi: 10.1038/s41467-023-37871-5 – volume: 16 start-page: 45 year: 1996 ident: pone.0293700.ref098 article-title: Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis publication-title: Rheumatol Int doi: 10.1007/BF01816434 – volume: 16 start-page: 1167 year: 2019 ident: pone.0293700.ref086 article-title: Transport of the Ruthenium Complex [Ru(GA)(dppe)2]PF6 into Triple-Negative Breast Cancer Cells Is Facilitated by Transferrin Receptors publication-title: Mol Pharm doi: 10.1021/acs.molpharmaceut.8b01154 – volume: 42 start-page: 826 year: 2019 ident: pone.0293700.ref088 article-title: Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor publication-title: Oncol Rep – volume: 6 start-page: e00136 year: 2014 ident: pone.0293700.ref097 article-title: Iron chelation and multiple sclerosis publication-title: ASN Neuro – volume: 397 start-page: 1750 year: 2021 ident: pone.0293700.ref089 article-title: Breast cancer publication-title: Lancet doi: 10.1016/S0140-6736(20)32381-3 – volume: 48 start-page: D77 year: 2020 ident: pone.0293700.ref051 article-title: Expression Atlas update: from tissues to single cells publication-title: Nucleic Acids Res – volume: 38 start-page: 3823 year: 1978 ident: pone.0293700.ref019 article-title: Growth of a human breast cancer cell line in serum-free hormone-supplemented medium publication-title: Cancer Res – volume: 30 start-page: 207 year: 2002 ident: pone.0293700.ref049 article-title: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository publication-title: Nucleic Acids Res doi: 10.1093/nar/30.1.207 – volume: 6 start-page: 1779 year: 2007 ident: pone.0293700.ref067 article-title: FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells publication-title: Cell Cycle doi: 10.4161/cc.6.14.4448 – volume: 12 start-page: 469 year: 1988 ident: pone.0293700.ref011 article-title: Preliminary evaluation of platinum transferrin (MPTC-63) as a potential nontoxic treatment for breast cancer publication-title: Cancer Detect Prev – volume: 95 start-page: 557 year: 2010 ident: pone.0293700.ref094 article-title: Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias publication-title: Haematologica doi: 10.3324/haematol.2009.014696 – volume: 9 start-page: R37 year: 2007 ident: pone.0293700.ref069 article-title: Molecular response to aromatase inhibitor treatment in primary breast cancer publication-title: Breast Cancer Res doi: 10.1186/bcr1732 – volume: 59 start-page: 51 year: 2018 ident: pone.0293700.ref008 article-title: Noninvasive (89)Zr-Transferrin PET Shows Improved Tumor Targeting Compared with (18)F-FDG PET in MYC-Overexpressing Human Triple-Negative Breast Cancer publication-title: J Nucl Med doi: 10.2967/jnumed.117.192286 – volume: 37 start-page: 75 year: 2018 ident: pone.0293700.ref077 article-title: Lipid accumulation in human breast cancer cells injured by iron depletors publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-018-0737-z – volume: 115 start-page: 11060 year: 2018 ident: pone.0293700.ref093 article-title: Metastatic growth instructed by neutrophil-derived transferrin publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1811717115 – volume: 119 start-page: 685 year: 2010 ident: pone.0293700.ref041 article-title: Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-009-0651-3 – volume: 76 start-page: 3484 year: 2016 ident: pone.0293700.ref058 article-title: Antagonizing Integrin beta3 Increases Immunosuppression in Cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-15-2663 – volume: 56 start-page: 203 year: 1999 ident: pone.0293700.ref066 article-title: Transferrin receptor overexpression enhances transferrin responsiveness and the metastatic growth of a rat mammary adenocarcinoma cell line publication-title: Breast Cancer Res Treat doi: 10.1023/A:1006209714287 – volume: 181 start-page: 115 year: 2020 ident: pone.0293700.ref002 article-title: Behavior of metastatic breast cancer according to subtype publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-020-05597-3 – volume: 12 start-page: 101 year: 2019 ident: pone.0293700.ref034 article-title: GENT2: an updated gene expression database for normal and tumor tissues publication-title: BMC Med Genomics doi: 10.1186/s12920-019-0514-7 – year: 2001 ident: pone.0293700.ref073 article-title: Mouse 4T1 breast tumor model publication-title: Curr Protoc Immunol – year: 2021 ident: pone.0293700.ref037 article-title: Curation of over 10 000 transcriptomic studies to enable data reuse publication-title: Database (Oxford) – volume: 70 start-page: 7 year: 2020 ident: pone.0293700.ref001 article-title: Cancer statistics, 2020 publication-title: CA Cancer J Clin doi: 10.3322/caac.21590 – volume: 10 start-page: 23759 year: 2020 ident: pone.0293700.ref014 article-title: Effects of core titanium crystal dimension and crystal phase on ROS generation and tumour accumulation of transferrin coated titanium dioxide nanoaggregates publication-title: RSC Adv doi: 10.1039/D0RA01878C – volume: 8 start-page: 15081 year: 2017 ident: pone.0293700.ref050 article-title: Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer publication-title: Nat Commun doi: 10.1038/ncomms15081 – volume: 52 start-page: 232 year: 2019 ident: pone.0293700.ref029 article-title: Desferrioxamine-caffeine shows improved efficacy in chelating iron and depleting cancer stem cells publication-title: J Trace Elem Med Biol doi: 10.1016/j.jtemb.2019.01.004 – volume: 14 start-page: 2473 year: 2015 ident: pone.0293700.ref056 article-title: CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-15-0252 – volume: 18 start-page: 435 year: 2013 ident: pone.0293700.ref006 article-title: Cellular iron metabolism in prognosis and therapy of breast cancer publication-title: Crit Rev Oncog doi: 10.1615/CritRevOncog.2013007784 – volume: 99 start-page: 1222 year: 1999 ident: pone.0293700.ref079 article-title: Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice publication-title: Circulation doi: 10.1161/01.CIR.99.9.1222 – volume: 1402 start-page: 239 year: 1998 ident: pone.0293700.ref085 article-title: Measuring transferrin receptor gene expression by NMR imaging publication-title: Biochim Biophys Acta doi: 10.1016/S0167-4889(98)00002-0 – volume: 37 start-page: 4799 year: 2017 ident: pone.0293700.ref030 article-title: Inhibitory Activity of Iron Chelators ATA and DFO on MCF-7 Breast Cancer Cells and Phosphatases PTP1B and SHP2 publication-title: Anticancer Res – year: 2021 ident: pone.0293700.ref054 article-title: Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore publication-title: J Clin Pathol – volume: 302 start-page: E77 year: 2012 ident: pone.0293700.ref078 article-title: Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00033.2011 – volume: 22 start-page: 8967 year: 2016 ident: pone.0293700.ref103 article-title: Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma publication-title: World J Gastroenterol doi: 10.3748/wjg.v22.i40.8967 – volume: 98 start-page: 525 year: 2001 ident: pone.0293700.ref080 article-title: H ferritin knockout mice: a model of hyperferritinemia in the absence of iron overload publication-title: Blood doi: 10.1182/blood.V98.3.525 – volume: 39 start-page: 175 year: 2007 ident: pone.0293700.ref060 article-title: G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences publication-title: Behav Res Methods doi: 10.3758/BF03193146 – volume: 10 start-page: 10309 year: 2020 ident: pone.0293700.ref075 article-title: Multiplexed non-invasive tumor imaging of glucose metabolism and receptor-ligand engagement using dark quencher FRET acceptor publication-title: Theranostics doi: 10.7150/thno.45825 – volume: 104 start-page: 1311 year: 2008 ident: pone.0293700.ref074 article-title: APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice publication-title: J Cell Biochem doi: 10.1002/jcb.21709 – volume: 11 start-page: e0154842 year: 2016 ident: pone.0293700.ref099 article-title: Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial publication-title: PLoS One doi: 10.1371/journal.pone.0154842 – volume: 121 start-page: 19 year: 2018 ident: pone.0293700.ref035 article-title: Making Use of Cancer Genomic Databases publication-title: Curr Protoc Mol Biol doi: 10.1002/cpmb.49 – volume: 60 start-page: 14 year: 2020 ident: pone.0293700.ref004 article-title: Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2019.08.012 – volume: 28 start-page: 2163 year: 2012 ident: pone.0293700.ref068 article-title: Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells publication-title: Oncol Rep doi: 10.3892/or.2012.2060 – volume: 11 start-page: 4544 year: 2021 ident: pone.0293700.ref012 article-title: Doxorubicin-transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells publication-title: Sci Rep doi: 10.1038/s41598-021-84146-4 – volume: 410 start-page: 69 year: 1986 ident: pone.0293700.ref021 article-title: Transferrin receptor (TrfR) expression in breast carcinoma and its possible relationship to prognosis publication-title: An immunohistochemical study. Virchows Arch A Pathol Anat Histopathol doi: 10.1007/BF00710908 – volume: 46 start-page: 255 year: 1989 ident: pone.0293700.ref064 article-title: Ki-67 immunoreactivity in breast carcinomas in relation to transferrin receptor expression, estrogen receptor status and morphological criteria. An immunohistochemical study publication-title: Oncology doi: 10.1159/000226727 – volume: 391 start-page: 1023 year: 2018 ident: pone.0293700.ref003 article-title: Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries publication-title: Lancet doi: 10.1016/S0140-6736(17)33326-3 – volume: 9 start-page: 402 year: 2003 ident: pone.0293700.ref082 article-title: Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311 publication-title: Clin Cancer Res – volume: 18 start-page: 850 year: 2018 ident: pone.0293700.ref042 article-title: Association of tamoxifen resistance and lipid reprogramming in breast cancer publication-title: BMC Cancer doi: 10.1186/s12885-018-4757-z – volume: 7 start-page: 71 year: 1986 ident: pone.0293700.ref063 article-title: Transferrin receptor is inversely correlated with estrogen receptor in breast cancer publication-title: Breast Cancer Res Treat doi: 10.1007/BF01806791 – volume: 7 start-page: 1398 year: 2017 ident: pone.0293700.ref095 article-title: Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease publication-title: Sci Rep doi: 10.1038/s41598-017-01402-2 – volume: 337 start-page: 1304 year: 1991 ident: pone.0293700.ref102 article-title: Intramuscular desferrioxamine in patients with Alzheimer’s disease publication-title: Lancet doi: 10.1016/0140-6736(91)92978-B – volume: 12 start-page: 4359 year: 2019 ident: pone.0293700.ref076 article-title: Deferoxamine-induced high expression of TfR1 and DMT1 enhanced iron uptake in triple-negative breast cancer cells by activating IL-6/PI3K/AKT pathway publication-title: Onco Targets Ther doi: 10.2147/OTT.S193507 – volume: 119 start-page: 283 year: 2010 ident: pone.0293700.ref062 article-title: Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-009-0345-x – volume: 17 start-page: 45 year: 2015 ident: pone.0293700.ref044 article-title: Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases publication-title: Breast Cancer Res doi: 10.1186/s13058-015-0558-3 – volume: 6 start-page: 38343 year: 2016 ident: pone.0293700.ref090 article-title: Iron chelators target both proliferating and quiescent cancer cells publication-title: Sci Rep doi: 10.1038/srep38343 – volume: 365 start-page: 576 year: 2011 ident: pone.0293700.ref101 article-title: Deferoxamine for advanced hepatocellular carcinoma publication-title: N Engl J Med doi: 10.1056/NEJMc1105726 – volume: 58 start-page: 95 year: 2010 ident: pone.0293700.ref055 article-title: A robust automated measure of average antibody staining in immunohistochemistry images publication-title: J Histochem Cytochem doi: 10.1369/jhc.2009.953554 – volume: 62 start-page: 4132 year: 2002 ident: pone.0293700.ref070 article-title: Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action publication-title: Cancer Res – volume: 26 start-page: 1037 year: 2011 ident: pone.0293700.ref040 article-title: Basal-like molecular subtype and HER4 up-regulation and response to neoadjuvant chemotherapy in breast cancer publication-title: Oncol Rep – volume: 77 start-page: 6299 year: 2017 ident: pone.0293700.ref053 article-title: Bone-Induced Expression of Integrin beta3 Enables Targeted Nanotherapy of Breast Cancer Metastases publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-17-1225 – volume: 420 start-page: 563 year: 2002 ident: pone.0293700.ref052 article-title: Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs publication-title: Nature doi: 10.1038/nature01266 – volume: 26 start-page: 105799 year: 2023 ident: pone.0293700.ref072 article-title: Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach publication-title: iScience doi: 10.1016/j.isci.2022.105799 – volume: 387 start-page: 2045 year: 2022 ident: pone.0293700.ref096 article-title: Trial of Deferiprone in Parkinson’s Disease publication-title: N Engl J Med doi: 10.1056/NEJMoa2209254 – volume: 347 start-page: 1 year: 2014 ident: pone.0293700.ref016 article-title: Iron homeostasis in breast cancer publication-title: Cancer Lett doi: 10.1016/j.canlet.2014.01.029 – volume: 20 start-page: 1215 year: 2020 ident: pone.0293700.ref031 article-title: Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment publication-title: BMC Cancer doi: 10.1186/s12885-020-07673-9 – volume: 464 start-page: 999 year: 2010 ident: pone.0293700.ref057 article-title: Genome remodelling in a basal-like breast cancer metastasis and xenograft publication-title: Nature doi: 10.1038/nature08989 – volume: 13 start-page: e1005352 year: 2017 ident: pone.0293700.ref017 article-title: Activated Oncogenic Pathway Modifies Iron Network in Breast Epithelial Cells: A Dynamic Modeling Perspective publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1005352 – volume: 74 start-page: 497 year: 2014 ident: pone.0293700.ref015 article-title: IRP2 regulates breast tumor growth publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-13-1224 – volume: 21 start-page: 5371 year: 2015 ident: pone.0293700.ref043 article-title: Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-14-2155 – volume: 10 start-page: 370 year: 2015 ident: pone.0293700.ref023 article-title: Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers publication-title: Nat Nanotechnol doi: 10.1038/nnano.2015.17 – year: 2023 ident: pone.0293700.ref061 article-title: Triple negative breast tumors contain heterogeneous cancer cells expressing distinct KRAS-dependent collective and disseminative invasion programs publication-title: Oncogene – volume: 37 start-page: 684 year: 2019 ident: pone.0293700.ref100 article-title: A phase I study of the safety and tolerability of VLX600, an Iron Chelator, in patients with refractory advanced solid tumors publication-title: Invest New Drugs doi: 10.1007/s10637-018-0703-9 – volume: 19 start-page: 2775 year: 2013 ident: pone.0293700.ref038 article-title: Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistance publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-1000 – volume: 82 start-page: 104 year: 2019 ident: pone.0293700.ref032 article-title: Treatment With Topical Deferoxamine Improves Cutaneous Vascularity and Tissue Pliability in an Irradiated Animal Model of Tissue Expander-Based Breast Reconstruction publication-title: Ann Plast Surg doi: 10.1097/SAP.0000000000001655 – volume: 38 start-page: 675 year: 2020 ident: pone.0293700.ref036 article-title: Visualizing and interpreting cancer genomics data via the Xena platform publication-title: Nat Biotechnol doi: 10.1038/s41587-020-0546-8 – volume: 2 start-page: 1141 year: 2019 ident: pone.0293700.ref087 article-title: Electrospray Functionalization of Titanium Dioxide Nanoparticles with Transferrin for Cerenkov Radiation Induced Cancer Therapy publication-title: ACS Appl Bio Mater doi: 10.1021/acsabm.8b00755 – volume: 46 start-page: 683 year: 2005 ident: pone.0293700.ref010 article-title: Preparation, biodistribution, and small animal PET of 45Ti-transferrin publication-title: J Nucl Med – volume: 66 start-page: 2749 year: 2006 ident: pone.0293700.ref083 article-title: Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-3857 – volume: 26 start-page: 85 year: 2019 ident: pone.0293700.ref018 article-title: Perturbation of Iron Metabolism by Cisplatin through Inhibition of Iron Regulatory Protein 2 publication-title: Cell Chem Biol doi: 10.1016/j.chembiol.2018.10.009 – volume: 119 start-page: 1487 year: 2018 ident: pone.0293700.ref039 article-title: Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit publication-title: Br J Cancer doi: 10.1038/s41416-018-0318-0 – volume: 10 start-page: 433 year: 1989 ident: pone.0293700.ref065 article-title: Correlation of proliferative activity with pathological features in breast carcinoma publication-title: Eur J Gynaecol Oncol – volume: 11 start-page: 626812 year: 2020 ident: pone.0293700.ref092 article-title: Iron Metabolism in the Tumor Microenvironment: Contributions of Innate Immune Cells publication-title: Front Immunol doi: 10.3389/fimmu.2020.626812 – volume: 21 start-page: 1777 year: 2001 ident: pone.0293700.ref007 article-title: Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene publication-title: Anticancer Res – volume: 17 year: 2018 ident: pone.0293700.ref033 article-title: High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines publication-title: Technol Cancer Res Treat doi: 10.1177/1533033818764470 – volume: 337 start-page: 521 year: 2021 ident: pone.0293700.ref013 article-title: Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo publication-title: J Control Release doi: 10.1016/j.jconrel.2021.07.048 – volume: 8 start-page: e80269 year: 2013 ident: pone.0293700.ref025 article-title: Non-invasive in vivo imaging of near infrared-labeled transferrin in breast cancer cells and tumors using fluorescence lifetime FRET publication-title: PLoS One doi: 10.1371/journal.pone.0080269 – volume: 39 start-page: 403 year: 2005 ident: pone.0293700.ref091 article-title: Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2005.03.029 – volume: 23 start-page: 93 year: 2021 ident: pone.0293700.ref046 article-title: Transcriptome analysis of heterogeneity in mouse model of metastatic breast cancer publication-title: Breast Cancer Res doi: 10.1186/s13058-021-01468-x – volume: 16 start-page: R25 year: 2014 ident: pone.0293700.ref048 article-title: A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity publication-title: Breast Cancer Res doi: 10.1186/bcr3625 – volume: 8 start-page: e53983 year: 2013 ident: pone.0293700.ref071 article-title: Transcriptional shift identifies a set of genes driving breast cancer chemoresistance publication-title: PLoS One doi: 10.1371/journal.pone.0053983 – volume: 11 year: 2019 ident: pone.0293700.ref009 article-title: Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells publication-title: Pharmaceutics – volume: 6 start-page: 221 year: 2009 ident: pone.0293700.ref022 article-title: Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2 publication-title: Mol Pharm doi: 10.1021/mp800149s – volume: 119 start-page: e2200200119 year: 2022 ident: pone.0293700.ref024 article-title: Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer-a preclinical study publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.2200200119 – volume: 15 start-page: 323 year: 2017 ident: pone.0293700.ref028 article-title: An epirubicin-peptide conjugate with anticancer activity is dependent upon the expression level of the surface transferrin receptor publication-title: Mol Med Rep doi: 10.3892/mmr.2016.6004 – volume: 64 start-page: 8604 year: 2004 ident: pone.0293700.ref059 article-title: CXCR4 regulates growth of both primary and metastatic breast cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-1844 – volume: 410 start-page: 1071 year: 2018 ident: pone.0293700.ref005 article-title: Selection and identification of transferrin receptor-specific peptides as recognition probes for cancer cells publication-title: Anal Bioanal Chem doi: 10.1007/s00216-017-0664-4 |
| SSID | ssj0053866 |
| Score | 2.495945 |
| Snippet | Conjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these biomaterials... Background Conjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these... BackgroundConjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these... Background Conjugation of transferrin (Tf) to imaging or nanotherapeutic agents is a promising strategy to target breast cancer. Since the efficacy of these... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0293700 |
| SubjectTerms | Adjuvant treatment Animal models Animals Antibodies Biological products Biomaterials Biomedical materials Body fat Bone biomaterials Bone cancer Bone tumors Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - genetics Cancer Care and treatment Causes of Chelating Agents Chelation Chemotherapy Conjugation Datasets Deferoxamine Diagnosis DNA microarrays Drug approval Female Gene Expression General anesthesia Genes Genomes Health aspects Human subjects Humans In vivo methods and tests Iron Kidney cancer Localization Medicine and Health Sciences Metastases Metastasis Mice Modulation Molecular Targeted Therapy Nanoparticles Patient outcomes Receptors Receptors, Transferrin - metabolism Research and Analysis Methods Surveys Tracers Transferrin Transferrin - metabolism Transferrins Tumors Viral antibodies Xenotransplantation |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquBAgYhAYe0TvxIzK2gVgUJkICi3iLbsWGlNlk1WYm_wT9mJvFGG1SpHLit4nF2MzOex2bmG0JeWFNqKZRNZaghQZHcplY7OO7aBl2rzCuD3cgfP6mTU_HhTJ5tjfrCmrARHnhk3IFmzIOfqqV0QmgXtK_rAFpW1FpkRgyhEdNsk0yNNhhOsVKxUY4X2UGUy_6qbfw-Aw9XYEfbliMa8Ponq7xYnbfdVSHn35WTW67o-Da5FWNIejj-9h1ywzd3yE48pR19FaGkX98lvwdXFBB9saFg2_wKUmwKn1cjyAQ1TU0vfG-wr2jpqMUS9Z46VIXLN_RoggKnbaD-VyyabYZt27MB6EVbxzlgtG_pcvinwsPVOHuXjgXn4CbvkdPjo2_vTtI4hCF1SvM-LTRTJnjtPMQS4MxNYWpueLCsDNIEZ3PPS8tNKBXPTO5U5vBdqxW6YMI4ze-TRQNs3yVUaVnCmgQpBhGc0QYMSh6AilkIZIqE8I1EKhcRynFQxnk1vHYrIFMZGVyhHKsox4Sk067IvGvo36KwJ1rE1x4ugNZVUeuq67QuIU9RVaqxWXWyEtVhUSDAm2QqIc8HCsTYaLCI54dZd131_vP3fyD6-mVG9DIShRbY4UxsnIBnQuyuGeXejBIshZst76Jib7jSVRxh43kmpICdG2W_evnZtIw3xcK8xrfrrso15AQ4_SxPyIPxbEyc5djEXOL3lrNTM2P9fKVZ_hwgzjPwPBA8sof_Q1iPyM0cQlMsQsrZHln0l2v_GELJ3j4ZrMYf3wB2bg priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELbK9sIFUV5dKGAQEnBIm8SxEyMh1KJWBYkFFYp6i2zHLiu1ybLJSvwN_jEziRM2qAJuq3icTWY8D8cz3xDyTKtM8kTogLsCNiic6UBLA-outZOFiKxQWI38YSaOT5P3Z_xsg8z6WhhMq-xtYmuoi8rgN_I9hhDXLEp48mbxPcCuUXi62rfQUL61QvG6hRi7RjbBJPNwQjYPDmefTnrbDNothC-gY2m05-W1u6hKuxvC_VOsdFtzUC2O_2CtJ4uLqr4qFP0zo3LNRR3dJDd8bEn3u8WwRTZseYtsee2t6QsPMf3yNvnZuiiHqIwlBZtnF7D1pvB70YFPUFUW9NI2CuuN5oZqTF1vqMElsnxFDweIcFo5an_4ZNqynbbeM4BeVoXvD0abis7bLxgWrvqevLRLRAf3eYecHh1-eXsc-OYMgRGSNUEqQ6GclcZCjAFOXqWqYIo5HWaOK2d0bFmmmXKZYJGKjYgMnsHqRKZhooxkd8mkBLZvEyokz2CMS-Nc4oySCgxN7IAq1BDgpFPCeonkxiOXYwONi7w9jkthB9MxOEc55l6OUxIMszzz_kF_gMIeaBF3u71QLc9zr8a5DEMLUVPBuUkSeF5pi8KBzUsLmUQqUVPyGJdK3hWxDtYj309TBH7joZiSpy0FYm-UmNxzrlZ1nb_7-PU_iD6fjIieeyJXATuM8gUV8E6I6TWi3BlRggUxo-FtXNg9V-r8t67BzH6xXz38ZBjGm2LCXmmrVZ3HEvYK2BUtnpJ7nW4MnGVY3Jzh_2YjrRmxfjxSzr-10OcReCQIKsP7f3-uB-R6DMEoph3F4Q6ZNMuVfQjBY6MfeYvwC0lgdDs priority: 102 providerName: ProQuest |
| Title | Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38117806 https://www.proquest.com/docview/3072931454 https://www.proquest.com/docview/2904573162 https://pubmed.ncbi.nlm.nih.gov/PMC10732420 https://doaj.org/article/900e008d55c449cf9eddf7877d941a4a http://dx.doi.org/10.1371/journal.pone.0293700 |
| Volume | 18 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdG98ILYnytYxSDkICHVEmcLyMhtE0tA4mBBkV9i2zHHpW6pDStNP4M_mPuHDdaUBF7iar4nLZn31d89ztCXkiR8ThKpBebAgKUmElPcgXizqXhRRLoRGA18qez5HQSfZzG0x2y6dnqGFhvDe2wn9RkOR9e_fz1DgT-re3akAabScNFVeqhD_Yr9SGI37UnRpjMF7XnCiDd9vQSvRYvCX3miun-9ZSOsbKY_q3m7i3mVb3NLf07u_KauRrfJXecn0mPmo2xR3Z0eY_sOUmu6SsHN_36PvltzZVBhMaSgv7TCwjDKXxeNEAUVJQFvdQrgbVHM0UlprGvqMLtsnxDRy1cOK0M1Vcusba00673D6CXVeF6hdFVRWf2bYaGu64_L22S0sGUPiCT8ejbyannGjV4KuFs5aXcT4TRXGnwN8Dgi1QUTDAj_czEwigZapZJJkyWsECEKgkUnsfKiKd-JBRnD0mvBLbvE5rwOIOxmCtjIqMEF6B0QgNUvgRnJ-0TtlmRXDkUc2ymMc_t0VwK0UzD4BzXMXfr2CdeO8sx7z_0x7jYLS1icNsb1fIidyKdc9_X4EEVcayiCH4v10VhQP-lBY8CEYk-eYpbJW8KWltNkh-lKYLAxX7SJ88tBeJwlJjocyHWdZ1_-Pz9BkRfzztELx2RqYAdSrjiCvhPiO_VoTzsUII2UZ3hfdzYG67UOUNoeRZEcQQzN5t9-_Czdhgfisl7pa7WdR5yiBuwQ1rYJ48a2Wg5y7DQOcPvzTpS02F9d6Sc_bAw6AFYJ3Aw_YObMOgxuR2Ce4qJSKF_SHqr5Vo_AXdyJQfkVjpN4ZqdBHgdvx-Q3ePR2ZfzgX1BM7Aa5A9V4HyJ |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELem7gFeEOPfCoMZBAIesuV_YqQJbdCpZVtBY5v2ZhzHHpW2pDSpgI_BF-KzcZc4oUET8LK3Kr6kyd357mzf_Y6Qp4mIWeCHiRXoFBYogZdYCZMw3VmiWRo6KhRYjXwwDofH_rvT4HSJ_GxqYTCtsrGJlaFOc4l75JseQlx7jh_4r6dfLOwahaerTQsNYVorpFsVxJgp7NhT37_CEq7YGr0FeT9z3d3B0ZuhZboMWDJkXmlFzA6FVkwqcJbgrUQkUk94OrFjHQgtE1d5ceIJHYeeI1wZOhIPExOfRbYvJIIxgQtY9nEDpUeWdwbjD4eNLwBrEoamYM-LnE2jHxvTPFMbNnxPhJV1Cw6x6hvQeofe9DwvLgt9_8zgXHCJuzfJDRPL0u1a-VbIkspukRVjLQr6wkBav7xNflQuUSMKZEbBxqopLPUp_J7WYBdUZCm9UKXA-qaJpAmmypdUokrOXtFBC0lOc03VN5O8m1W3LfYooBd5avqR0TKnk2rHRMFV0wOY1onv4K7vkOMrEdNd0suA7auEhiyIYSxgUmtfS8EEGDZXA5WdQEAV9YnXSIRLg5SODTvOeXX8F8GKqWYwRzlyI8c-sdq7DPP-Qb-Dwm5pEee7upDPzrgxG5zZtoIoLQ0C6fvwvkylqQYbG6XMd4Qv-mQdVYXXRbOtteLbUYRAc4Ed9smTigKxPjJMJjoT86Lgo_cn_0H08bBD9NwQ6RzYIYUp4IBvQgyxDuVahxIsluwMr6JiN1wp-O-5DXc2yn758ON2GB-KCYKZyucFdxmsTbALm9sn9-q50XLWw2LqGP837syaDuu7I9nkcwW17oAHhCDWvv_391on14ZHB_t8fzTee0CuuxAIY8qTa6-RXjmbq4cQuJbJI2MdKPl01QbpFxcZsaY |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELemTkK8IMa_FQYzCAQ8ZM1fJ0aa0MZarQzKNBjaW3Ace1TaktKkAj4GX4tPxV3ihAZNwMveqvicJmf7d-f47neEPE5ExAOfJVagU9igBF5iJVzCcueJ5ilzFBOYjfx2wvaP_dcnwckK-dnkwmBYZYOJFVCnucRv5AMPKa49xw_8gTZhEYd7o5ezLxZWkMKT1qachjBlFtLtim7MJHkcqO9fYTtXbI_3YOyfuO5o-OHVvmUqDliSca-0Qm4zoRWXCgwnWC4RitQTnk7sSAdCy8RVXpR4QkfMc4QrmSPxYDHxeWj7QiIxE5iD1RCsPmwEV3eHk8Ojxi4AsjBmkve80BmYubI1yzO1ZcO7hZhlt2QcqxoCraXozc7y4iI3-M9oziXzOLpOrhm_lu7UE3GNrKjsBlkzyFHQZ4be-vlN8qMyjxoZITMKeKtmsO2n8HtWE19QkaX0XJUCc52mkiYYNl9SidNz_oIOW3pymmuqvplA3qzqtlyvgJ7nqalNRsucTquvJwqumnrAtA6CB9N9ixxfyjDdJr0M1L5OKONBBG0Bl1r7WgouAORcDVJ2As5V2CdeMyKxNKzpWLzjLK6OAkPYPdUKjnEcYzOOfWK1vYzy_iG_i4PdyiLnd3Uhn5_GBkJibtsKPLY0CKTvw_NylaYa8DZMue8IX_TJJk6VuE6gbZEr3glDJJ0LbNYnjyoJ5P3IcAWdikVRxON3H_9D6P1RR-ipEdI5qEMKk8wB74R8Yh3JjY4koJfsNK_jxG60UsS_1zn0bCb7xc0P22a8KQYLZipfFLHLYZ-CFdncPrlTr41Wsx4mVkf4v1Fn1XRU323Jpp8r2nUHrCE4tPbdvz_XJrkCwBS_GU8O7pGrLvjEGP3k2hukV84X6j74sGXywIADJZ8uG49-AYG9teo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transferrin+receptor+in+primary+and+metastatic+breast+cancer%3A+Evaluation+of+expression+and+experimental+modulation+to+improve+molecular+targeting&rft.jtitle=PloS+one&rft.au=Fontana%2C+Francesca&rft.au=Esser%2C+Alison+K&rft.au=Egbulefu%2C+Christopher&rft.au=Karmakar%2C+Partha&rft.date=2023-12-20&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=18&rft.issue=12&rft_id=info:doi/10.1371%2Fjournal.pone.0293700&rft.externalDBID=ISR&rft.externalDocID=A776810506 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |